DJIA 17,291.88 96.46 0.56%
NASDAQ 4,641.14 75.00 1.64%
S&P 500 2,013.07 18.42 0.92%
market minute promo

GlaxoSmithKline (NYSE: GSK)

45.25 0.11 (0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $45.24 0.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $45.29
Previous Close $45.14
Daily Range $45.29 - $45.30
52-Week Range $41.91 - $56.73
Market Cap $108.7B
P/E Ratio 15.51
Dividend (Yield) $2.45 (5.9%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 100,706
Average Daily Volume 6,636,422
Current FY EPS $3.09

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Seattle Genetics, Inc. Posts Record Adcetris Sales

A solid quarter for the biotech allowed it to raise guidance for the year.

United Therapeutics Sells Off On Good News - Why I Bought That Dip

5 Things GlaxoSmithKline plc Stock's Management Wants You to Know

GlaxoSmithKline held its third-quarter conference call last week. Here's what the company's management wants you to know.

Ebola Vaccine Contenders

Novartis (NVS) Beats on Q3 Earnings, Revenues; Keeps View - Analyst Blog

Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog

Is Sanofi's Ouster of Viehbacher a Mistake?

Sanofi has jettisoned its long time CEO, but that might not be the best decision given challenges that lay ahead.

Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success

5 Stocks To Consider When Playing Ebola

3 Stocks Dragging The Health Care Sector Downward

See More GSK News...

GSK's Top Competitors

GSK $45.25 (0.24%)
Current stock: GSK
JNJ $107.64 (0.56%)
Current stock: JNJ
NVS $92.55 (0.65%)
Current stock: NVS
RHHBY $36.97 (-0.58%)
Current stock: RHHBY